lbh589
Showing 1 - 25 of 30
Chronic Myeloid Leukemia in Chronic Phase Trial in Belgium, Germany (LBH589)
Terminated
- Chronic Myeloid Leukemia in Chronic Phase
- LBH589
-
Bruxelles, Belgium
- +9 more
Jul 14, 2021
Non-Hodgkin Lymphoma, Tumors Trial in Las Vegas, Rotterdam (LBH589)
Completed
- Non-Hodgkin Lymphoma
- Neoplasms
- LBH589
-
Las Vegas, Nevada
- +1 more
Dec 16, 2020
Cancer, Advanced Solid Tumor Trial in Aichi prefecture, Hokkaido, Hyogo prefecture (LBH589)
Completed
- Cancer
- Advanced Solid Tumor
- LBH589
-
Aichi prefecture, Japan
- +2 more
Dec 16, 2020
NSCLC, Mesothelioma Trial in Canada, United States (LBH589)
Completed
- Carcinoma, Non-Small-Cell Lung
- Mesothelioma
- LBH589
-
Fayetteville, Arkansas
- +4 more
Dec 16, 2020
Hormone Refractory Prostate Cancer Trial in United States (LBH589)
Terminated
- Hormone Refractory Prostate Cancer
- LBH589
-
Boston, Massachusetts
- +4 more
Dec 16, 2020
Cancer Trial in Sweden, Switzerland, United States (LBH589)
Completed
- Cancer
- LBH589
-
Los Angeles, California
- +8 more
Dec 16, 2020
Multiple Myeloma Trial in Worldwide (LBH589, Lenalidomide)
Completed
- Multiple Myeloma
- LBH589
- Lenalidomide
-
San Francisco, California
- +9 more
Dec 16, 2020
Multiple Myeloma Trial in Worldwide (LBH589)
Completed
- Multiple Myeloma
- LBH589
-
Miami Shores, Florida
- +15 more
Dec 16, 2020
Advanced Solid Tumors Trial in Worldwide (LBH589)
Completed
- Advanced Solid Tumors
- LBH589
-
Salt Lake City, Utah
- +5 more
Dec 16, 2020
Myelodysplastic Syndrome Trial in Houston (LBH589)
Terminated
- Myelodysplastic Syndrome
- LBH589
-
Houston, TexasUT MD Anderson Cancer Center
Jul 23, 2018
Myelodysplastic Syndrome (MDS) Trial in Germany (LBH589, Epoetin Alfa)
Terminated
- Myelodysplastic Syndrome (MDS)
- LBH589
- Epoetin Alfa
-
Mannheim, Baden-Württemberg, Germany
- +11 more
Aug 8, 2017
Melanoma, Malignant Melanoma Trial in Boston (LBH589)
Completed
- Melanoma
- Malignant Melanoma
- LBH589
-
Boston, MassachusettsDana-Farber Cancer Institute
Mar 27, 2017
Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Buffalo (LBH589)
Terminated
- Hodgkin's Lymphoma
- Non-Hodgkin's Lymphoma
- LBH589
-
Buffalo, New YorkRoswell Park Cancer Institute
Jan 11, 2017
Diffuse Large B Cell Lymphoma Trial in Halifax, Toronto, Montreal (LBH589, Rituximab)
Unknown status
- Diffuse Large B Cell Lymphoma
- LBH589
- Rituximab
-
Halifax, Nova Scotia, Canada
- +3 more
Dec 2, 2016
Diffuse Large B-cell Lymphoma Trial in Durham (RAD001, LBH589, Doublet (RAD001 and LBH589))
Terminated
- Diffuse Large B-cell Lymphoma
- RAD001
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Oct 12, 2016
Leukemia, Myeloid, Acute, MDS Trial in St. Louis (LBH589, Decitabine)
Completed
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
- LBH589
- Decitabine
-
St. Louis, MissouriWashington University
Aug 18, 2016
Breast Cancer Trial in Nashville (LBH589, Capecitabine, Lapatinib)
Completed
- Breast Cancer
- LBH589
- +2 more
-
Nashville, TennesseeTennessee Oncology, PLLC
Jun 4, 2015
Primary Myelofibrosis, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Post-Essential Thrombocythemia Related
Unknown status
- Primary Myelofibrosis
- +2 more
- LBH589
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Mar 5, 2015